World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
145
Citations
107231
World Ranking
1359
National Ranking
792

Research.com Recognitions

  • 2017 - Member of Academia Europaea

Overview

Jean-Charles Soria is affiliated with the Institut Gustave Roussy in France. Their research spans multiple fields within medicine and molecular biology, emphasizing oncology and pulmonary and respiratory medicine. Their work extensively covers cancer research and immunology, focused on various aspects of cancer immunotherapy and biomarkers, cancer genomics and diagnostics, and lung cancer treatments and mutations.

The scientist has published in several prominent journals, with frequent contributions to the following venues:

  • Annals of Oncology
  • Cancer Research
  • European Journal of Cancer
  • Journal of Clinical Oncology
  • Clinical Cancer Research

Their notable recent papers include:

  • Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer, 2022, Nature Medicine
  • Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression, 2021, Nature Cancer
  • Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy, 2021, Annals of Oncology
  • Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies, 2021, CA A Cancer Journal for Clinicians
  • Targeting the DNA damage response in immuno-oncology: developments and opportunities, 2021, Nature Reviews Cancer

Jean-Charles Soria frequently collaborates with a consistent group of coauthors, including:

  • Benjamin Besse
  • Christophe Massard
  • Aurélien Marabelle
  • Fabrice Barlési
  • Fabrice André

Their research focuses on key topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • COVID-19 and healthcare impacts
  • Economic and Financial Impacts of Cancer
  • CAR-T cell therapy research
  • COVID-19 Clinical Research Studies

Jean-Charles Soria was recognized as a Member of Academia Europaea in 2017.

Best Publications

  • Pembrolizumab for the treatment of non-small cell lung cancer

    Edward B. Garon;Naiyer A. Rizvi;Rina Hui;Natasha Leighl

  • Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

    Roy S. Herbst;Jean Charles Soria;Marcin Kowanetz;Gregg D. Fine

  • Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy;Bertrand Routy;Bertrand Routy;Lisa Derosa;Lisa Derosa;Lisa Derosa;Connie P. M. Duong;Connie P. M. Duong

  • Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

    Jean-Charles Soria;Yuichiro Ohe;Johan Vansteenkiste;Thanyanan Reungwetwattana

  • DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

    Ken A. Olaussen;Ariane Dunant;Pierre Fouret;Elisabeth Brambilla

  • Immune-related adverse events with immune checkpoint blockade: a comprehensive review

    J.M. Michot;C. Bigenwald;S. Champiat;M. Collins

  • Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

    Suresh S Ramalingam;Johan Vansteenkiste;David Planchard;Byoung Chul Cho

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

    Stephane Champiat;Stephane Champiat;Laurent Dercle;Samy Ammari;Christophe Massard

  • A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

    Roger Sun;Roger Sun;Elaine Johanna Limkin;Elaine Johanna Limkin;Maria Vakalopoulou;Maria Vakalopoulou;Laurent Dercle;Laurent Dercle

  • First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

    Jean-Charles Soria;Daniel S W Tan;Rita Chiari;Yi-Long Wu

  • Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

    Celine Boutros;Ahmad Tarhini;Emilie Routier;Olivier Lambotte

  • Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

    S. Champiat;S. Champiat;O. Lambotte;E. Barreau;R. Belkhir

  • Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

    Fabrice Barlesi;Julien Mazieres;Jean-Philippe Merlio;Didier Debieuvre

  • Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.

    Laura Mezquita;Edouard Auclin;Roberto Ferrara;Melinda Charrier

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028

    Patrick A. Ott;Yung Jue Bang;Sarina A. Piha-Paul;Albiruni R. Abdul Razak

  • Management of non-small-cell lung cancer: recent developments.

    Martin Reck;David F. Heigener;Tony Mok;Jean Charles Soria

  • Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

    Vivek Subbiah;Robert J. Kreitman;Zev A. Wainberg;Jae Yong Cho

  • Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

    Lecia V. Sequist;Jean Charles Soria;Jonathan W. Goldman;Heather A. Wakelee

Frequent Co-Authors

Benjamin Besse
Benjamin Besse University of Paris-Saclay
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
David Planchard
David Planchard Institut Gustave Roussy
Yohann Loriot
Yohann Loriot University of Paris-Saclay
Philippe Vielh
Philippe Vielh Institut Gustave Roussy
Thierry de Baere
Thierry de Baere Institut Gustave Roussy
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Aurélien Marabelle
Aurélien Marabelle Institut Gustave Roussy
Elisabeth Brambilla
Elisabeth Brambilla Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but looking for alternative pathways beyond the traditional MD, there are a variety of flexible online degrees and fast-track career options worth exploring. Many prospective students consider starting with nursing, and you may want to research what is the easiest nursing school to get into for a straightforward entry into the profession.

Some nursing schools provide a smoother admissions process by not requiring major entrance exams. If testing is a concern, review this list of nursing schools that don't require teas test. These programs can open doors for more students seeking a rewarding healthcare career.

For those interested in the administrative side, healthcare administration degrees are a popular online choice, providing leadership skills and business knowledge essential for managing clinics, hospitals, or healthcare organizations.

Additionally, the field of medical billing and coding offers entirely online educational opportunities and quick entry into the workforce. Learn more about top medical billing and coding online schools if you prefer working behind the scenes in healthcare.

Best Scientists Citing Jean-Charles Soria

Trending Scientists

Recently Published Articles